Profile and Survival of Women with Gynecological Cancer treated at an Oncology Center in Agreste Pernambuco, Brazil
DOI:
https://doi.org/10.21270/archi.v12i11.6130Keywords:
Genital Neoplasms, Female, Epidemiology, SurvivalAbstract
Introduction: Gynecological cancer, especially cervical cancer, has a high incidence among women and is a relevant cause of morbidity and death in Brazil. It becomes important to know the risks, epidemiological and behavioral data of the population involved with the tumors. Objective: To verify the epidemiological, clinical profile and the survival time of women with gynecological cancer treated in a reference service of oncology in Agreste Pernambuco. Material and Methods: The study was developed in an Oncology Center in the municipality of Caruaru-PE. The sample was composed of patients with gynecological cancer seen between January 2007 and December 2017. Results: 433 women were included, of which, 30 (6.93%) died during the study period. The mean age at diagnosis was 57.57 years (SD ± 34.71). The most frequent cancer identified was of the cervix (62.12%), followed by endometrium (19.40%), ovary (14.78%), vagina (2.54%) and vulva (1.15%). Regarding survival time, a total of 15 (50.00%) died in the first year of treatment, 06 (20.00%) in the second, 05 (16.67%) in the third, 02 (6.67%) in the fourth, 01 (3.33%) in the fifth, and 01 (3.33%) in the sixth year. There were no deaths between the 7th and 10th year after treatment. Conclusion: Cervical cancer was the most prevalent among the women included in this study, as for survival, the first year after treatment proved to be the most critical period for survival of patients.
Downloads
References
INCA -Instituto Nacional de Câncer. Estimativa 2020: incidência de câncer no Brasil. INCA -Instituto Nacional de Câncer. 2019.
INCA -Instituto Nacional de Câncer. Tipos de Câncer. Câncer de Ovário. INCA -Instituto Nacional de Câncer. 2018.
Costa C, Cunha, TM. Estadiamento do carcinoma do endométrio - O que há de novo? ARP. 2016; 28(107):13-20.
Adams TS, Rogers LJ, Cuello MA. Cancer of the vagina: 2021 update. Int J Gynaecol Obstet. 2021;155(Suppl 1):19-27.
Silva AM, Silva AM, Guedes GW, Souza Dantas AFL, Nóbrega MM. Perfil Epidemiológico Do Câncer Do Colo Do Útero Na Paraíba. Temas em Saúde. 2016; 16(4):180-97.
Batista MG, Ramos KS, Costa CBA. Perfil Sociodemográfico E Clínico De Mulheres Com Câncer Do Colo Do Útero Associado Ao Estadiamento Avançado. Rev Ciênc Saúde Nova Esperança. 2017;15(2):77-87.
Figueiredo T, Souza CQ, Castilho EM, Silva TMR, Silva EP, Siqueira LG, Souza LP. Análise do perfil de mulheres com lesões pré-cancerosas de colo do útero. Saúde em Revista. 2015;15(41):3-13.
Singh GK, Miller BA, Hankey BF, Edwards BK. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Câncer.2004;101(5):1051-57.
Prefeitura Municipal de Porto Alegre. Diretrizes Para Acolhimento e Assistência à Saúde das Mulheres Negras. Prefeitura de Porto Alegre (Procempa). 2014.
Nagelhout G, Ebisch RM, Van Der Hel O, Meerkerk GJ, Magnée T, De Bruijn T, Van Straaten B. Is smoking an independent risk factor for developing cervical intra-epithelial neoplasia and cervical cancer? A systematic review and meta-analysis. Expert Rev Anticancer Ther. 2021; 21(7):781-94.
INCA -Instituto Nacional de Câncer Estimativa 2020: Controle do câncer do colo do útero: Fatores de risco. INCA -Instituto Nacional de Câncer. 2018.
Almeida AF, Holmes ES, Lacerda CCC, Farias CF, Costa MBS, Santos SR. Métodos de detecção de câncer de colo uterino entre profissionais da saúde. Rev enferm UFPE. 2015;9(1):62-8.
Luiz BM, Miranda PF, Maia EMC, Machado RB, Giatti MJL, Antico Filho A, Borges JBR. Estudo Epidemiológico de Pacientes com tumor de ovário no município de Jundiaí no período de junho de 2001 a junho de 2006. Rev Bras Cancerol. 2009; 55(3):247-53.
Roman KEM, Panis C. Identificação dos fatores de risco associados ao desenvolvimento de câncer de colo uterino em mulheres. Infarma. 2011;23(1/2): 03-08.
Moya-Alarcón, C., González-Domínguez, A., Simon, S., Pérez-Román, I., González-Martín, A., Bayo-Lozano, E.Sánchez-Heras, A. B. Cost–utility analysis of germline BRCA1/2 testing in women with high-grade epithelial ovarian cancer in Spain. Clin Transl Oncol. 2018;1-9.
Raglan O, Kalliala I, Markozannes G, Cividini S, Gunter MJ, Nautiyal J, Gabra H, Paraskevaidis E, Martin-Hirsch P, Tsilidis KK, Kyrgiou M. Risk factors for endometrial cancer: An umbrella review of the literature. Int J Cancer.2019;145(7):1719-30.
Barreto CL. Sobrevida e Fatores de Prognóstico em Pacientes com Câncer Invasivo do Colo Uterino. Tese em Medicina Tropical, Universidade Federal de Pernambuco, Centro de Ciências da Saúde, Recife. 2012.
